BR0209834A - Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida - Google Patents

Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida

Info

Publication number
BR0209834A
BR0209834A BR0209834-2A BR0209834A BR0209834A BR 0209834 A BR0209834 A BR 0209834A BR 0209834 A BR0209834 A BR 0209834A BR 0209834 A BR0209834 A BR 0209834A
Authority
BR
Brazil
Prior art keywords
composition
unit dosage
dosage form
granular product
solid molded
Prior art date
Application number
BR0209834-2A
Other languages
English (en)
Inventor
Michiel Onne Elama
Lene Andresen
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0209834A publication Critical patent/BR0209834A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"PRODUTO GRANULADO FUNDIDO, PROCESSO PARA A PREPARAçãO DO MESMO, COMPOSIçãO, E, FORMA DE DOSAGEM UNITáRIA FARMACêUTICA MOLDADA SóLIDA". A presente invenção refere-se a um produto granulado contendo gaboxadol como um sal de adição de ácido, a um processo de granulação em fusão para a preparação do mesmo e às formas de dosagem unitárias farmacêuticas sólidas preparadas a partir da citada preparação granulada de gaboxadol.
BR0209834-2A 2001-05-21 2002-05-17 Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida BR0209834A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21
PCT/DK2002/000332 WO2002094225A1 (en) 2001-05-21 2002-05-17 Granular preparations of gaboxadol

Publications (1)

Publication Number Publication Date
BR0209834A true BR0209834A (pt) 2004-06-15

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209834-2A BR0209834A (pt) 2001-05-21 2002-05-17 Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida

Country Status (26)

Country Link
US (1) US20040157876A1 (pt)
EP (1) EP1389091A1 (pt)
JP (1) JP2004530695A (pt)
KR (1) KR20030097890A (pt)
CN (1) CN1511026A (pt)
AR (1) AR033896A1 (pt)
AU (1) AU2002338855B2 (pt)
BG (1) BG108441A (pt)
BR (1) BR0209834A (pt)
CA (1) CA2447603A1 (pt)
CZ (1) CZ20033269A3 (pt)
EA (2) EA200700703A1 (pt)
HR (1) HRP20030950A2 (pt)
HU (1) HUP0400051A2 (pt)
IL (1) IL158733A0 (pt)
IS (1) IS7020A (pt)
ME (1) MEP6308A (pt)
MX (1) MXPA03010596A (pt)
NO (1) NO20035146L (pt)
NZ (1) NZ547636A (pt)
PL (1) PL366541A1 (pt)
SK (1) SK15542003A3 (pt)
UA (1) UA80092C2 (pt)
WO (1) WO2002094225A1 (pt)
YU (1) YU92103A (pt)
ZA (1) ZA200308594B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510266A (ja) * 1999-09-28 2003-03-18 ハー・ルンドベック・アクチエゼルスカベット 溶融顆粒化された調合物及びこの調合物から製造された、放出が調節された投薬形
MXPA05013016A (es) 2003-06-25 2006-03-02 Lundbeck & Co As H Gaboxadol para el tratamiento de la depresion y otros trastornos afectivos.
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1848420A4 (en) 2005-01-28 2008-01-23 Merck & Co Inc POLYMORPHIC FORMS OF A GABAA AGONIST
WO2006118897A1 (en) * 2005-04-29 2006-11-09 H.Lundbeck A/S Acid and base salt forms of gaboxadol
CN103054868B (zh) * 2008-05-30 2016-08-31 赛科基因股份有限公司 用于神经和精神障碍的治疗
CA2732636A1 (en) * 2008-09-01 2009-05-07 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of pat1 or oat
WO2013090452A1 (en) 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
JP2003510266A (ja) * 1999-09-28 2003-03-18 ハー・ルンドベック・アクチエゼルスカベット 溶融顆粒化された調合物及びこの調合物から製造された、放出が調節された投薬形
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
AU2002338855B2 (en) 2007-08-16
US20040157876A1 (en) 2004-08-12
CN1511026A (zh) 2004-07-07
NO20035146D0 (no) 2003-11-19
UA80092C2 (en) 2007-08-27
CZ20033269A3 (en) 2004-03-17
KR20030097890A (ko) 2003-12-31
SK15542003A3 (sk) 2004-05-04
HUP0400051A2 (hu) 2004-04-28
AR033896A1 (es) 2004-01-07
NO20035146L (no) 2003-11-19
EA200301282A1 (ru) 2004-04-29
MXPA03010596A (es) 2004-03-09
PL366541A1 (en) 2005-02-07
EP1389091A1 (en) 2004-02-18
CA2447603A1 (en) 2002-11-28
IS7020A (is) 2003-11-10
YU92103A (sh) 2006-05-25
IL158733A0 (en) 2004-05-12
HRP20030950A2 (en) 2005-08-31
MEP6308A (xx) 2010-02-10
WO2002094225A1 (en) 2002-11-28
JP2004530695A (ja) 2004-10-07
EA200700703A1 (ru) 2007-08-31
ZA200308594B (en) 2004-11-04
EA009731B1 (ru) 2008-02-28
NZ547636A (en) 2008-03-28
BG108441A (en) 2005-02-28

Similar Documents

Publication Publication Date Title
MY142029A (en) Phenoxyacetic acid derivatives
TW200505837A (en) Novel compounds
SG149080A1 (en) Composition comprising a nsaid and paracetamol
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
GEP20156328B (en) Solid pharmaceutical compositions and processes for their production
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
BR0209834A (pt) Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida
DE50110617D1 (de) Pharmazeutische formulierungen enthaltend saccharosefettsäureester zur steuerung der wirkstofffreisetzung
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
BRPI0607614A2 (pt) sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso
BR0008872B1 (pt) processo para a produção de formas de dosagem sólidas, e, forma de dosagem sólida.
WO2007078848A3 (en) Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid
BR0116548A (pt) Composições farmacêuticas termoformáveis sólidas para liberação controlada de ivabradina
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
IL183779A0 (en) Vitamin d receptor modulators
DE60225262D1 (de) Granulatförmige zusammensetzungen und verfahren zu ihrer herstellung
DE50204789D1 (de) Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
BR0206964A (pt) Diamidas de ácido ftálico, um processo para a sua preparação e sua aplicação como composições praguicidas
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
SG161201A1 (en) Production process for nsaid-containing lozenges, their compositions, their medicinal use
BRPI0509582A (pt) compostos de tiazol-amina e respectivas composições farmacêuticas
BR0309853A (pt) Sistema mono-compartimentar de liberação de medicamento por controle osmótico e processo para sua preparação
SE0202686D0 (sv) Näringstillskott för djur
BR0112672A (pt) Formas de dosagem de divalproex de sódio e processo para a produção das mesmas
WO2004078734A8 (en) TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.